In the dynamic world of pharmaceuticals and biotechnology, regulatory affairs professionals play a crucial role in ensuring that products meet the stringent standards set by health authorities worldwide. One such distinguished professional is jennifer aggabao abbvie, whose extensive experience and leadership have significantly impacted the industry.
Educational Foundation
Jennifer aggabao abbvie laid the groundwork for her illustrious career by earning a Bachelor of Science (BS) degree from California State University, Long Beach. This academic achievement provided her with a solid foundation in scientific principles, essential for her future roles in regulatory affairs.
Early Career and Progression
Jennifer’s professional journey began in August 2001 as a Quality Control Analyst at Baxter International Inc., a global leader in medical products. Over the next several years, she ascended through various roles within the company:
- Quality Systems Specialist (October 2005 – October 2008): In this capacity, Jennifer was responsible for maintaining and improving quality management systems, ensuring compliance with regulatory standards.
- Associate, Global Regulatory Affairs, CMC Biologics (November 2008 – March 2010): Transitioning into regulatory affairs, she began focusing on Chemistry, Manufacturing, and Controls (CMC) for biologic products.
- Specialist, Global Regulatory Affairs, CMC Biologics (April 2010 – March 2012): Jennifer continued to deepen her expertise in CMC biologics, playing a pivotal role in regulatory submissions and strategy.
- Manager, Global Regulatory Affairs, CMC Biologics (April 2012 – April 2015): As a manager, she led teams in developing regulatory strategies for biologic products, ensuring successful submissions to health authorities.
Advancing in Regulatory Affairs
In May 2015, Jennifer joined Shire as the Global Regulatory Lead for Hematology. In this role, she oversaw regulatory strategies for hematology products, ensuring compliance and facilitating market approvals.
Her journey continued with Allergan, where she held several key positions:
- Senior Manager, Global Regulatory Affairs, CMC Biologics (September 2016 – December 2016): Jennifer led regulatory activities related to the CMC aspects of biologic products.
- Associate Director, Global Regulatory Affairs, CMC Biologics (January 2017 – February 2020): She provided strategic direction for regulatory submissions and interactions with health authorities.
- Director, Global Regulatory Affairs, CMC Biologics (March 2020 – May 2020): In this director-level role, Jennifer was responsible for overseeing global regulatory strategies for biologic products.
Tenure at AbbVie
In May 2020, Jennifer transitioned to AbbVie, a global biopharmaceutical company, as the Director of Global Regulatory Affairs, CMC Biologics. During her tenure, she:
- Led global regulatory strategies for the CMC aspects of biologic products.
- Collaborated with cross-functional teams to ensure compliance with international regulatory requirements.
- Played a key role in facilitating successful product approvals and lifecycle management.
Current Role at Revance
As of August 2022, Jennifer serves as the Executive Director of Global Regulatory Affairs at Revance. In this executive role, she:
- Leads the global regulatory affairs team, overseeing strategies for product development and approvals.
- Ensures compliance with regulatory standards across various markets.
- Guides the company through the complex landscape of global health authority requirements.
Conclusion
Jennifer aggabao abbviecareer trajectory exemplifies dedication, expertise, and leadership in the field of global regulatory affairs. Her contributions have been instrumental in bringing innovative therapies to market, ensuring that they meet the highest standards of quality and safety. As she continues her journey at Revance, the industry anticipates further advancements under her guidance.
